Physiology

Community support urged for breastfeeding moms and babies – Press Publications Inc.

August is National and World Breastfeeding Awareness Month, and on Aug. 1, Ohio. Gov. Mike DeWine and Lt. Gov. Jon Husted signed a proclamation that Ohio is joining in the observance. The State of Ohio joins the Surgeon General and the United States Breastfeeding Committee in the belief that Ohio breastfeeding rates will improve if social policy and community norms support breastfeeding mothers and babies, the proclamation said. For this years Breastfeeding Awareness Month, Ohio has adopted the theme, Support Breastfeeding for a Healthier Planet. This theme focuses on the impact of infant feeding on the environment and climate change and the imperative to protect, promote and support breastfeeding for the health of the planet and its people. The American Academy of Pediatrics and the World Health Organization recommend exclusive breastfeeding for the first six months of life and continued breastfeeding with the addition of appropriate solid food for the first year and beyond. The U.S. Centers for Disease Control and Prevention report that Ohios 2018 breastfeeding initiation rate of 81.9 percent ranks 36th in the nation. The CDC also states that rates of breastfeeding duration and exclusivity are lower among Black infants than among white infants. Increasing rates of breastfeeding initiation and supporting continuation of breastfeeding among Black women might help reduce disparities in breastfeeding duration. Strategies may include improving peer and family support, access to evidence-based maternity care, and employment support. In light of the financial and life-saving benefits of breastfeeding, all elements of the Wood County community must cooperate and support breastfeeding, said Jackie Mears, Wood County WIC (Women, Infants and Children) Director. Ultimately our whole society benefits from having healthier mothers, babies and children when breastfeeding is promoted, protected and supported. While breastfeeding is a personal choice, communities play a vital role in informing and supporting a mothers decision to breastfeed her baby, Mears said, adding that returning our communities to a breastfeeding supportive culture will take efforts by family, friends, employers, educational institutions, hospitals and businesses. The Wood County Health Department offers these suggestions for improving social policy and community norms to support breastfeeding mothers and babies.: Businesses and the community members can help mothers feel comfortable nursing in public. Hungry babies need to eat, and Ohio law allows breastfeeding in public. Businesses can show their support by placing the Breastfeeding Welcome Here universal sign for breastfeeding in their windows and educating their staff on the acceptance of breastfeeding in their establishments. Employers can also encourage employees and provide a private space (other than a bathroom) to pump. This will increase employee retention and reduce medical costs. Hospitals can adopt the Ten Steps to Successful Breastfeeding as an indication that they are dedicated to supporting new mothers who choose to breastfeed. Educational institutions can support breastfeeding by presenting age-appropriate education on the anatomy and physiology of the human body. Breastfeeding mothers can reach out through groups and chatrooms on social media to get the support they need. For more information about breastfeeding, contact a member of the Wood County WIC Breastfeeding Team at 419-354-9661 or adonaldson@co.wood.oh.us. The mission of Wood County Health Department is to prevent disease, promote healthy lifestyles and protect the health of everyone in Wood County. The departments Community Health Center provides comprehensive medical services for men, women and children. All patients are welcome, including uninsured or underinsured clients, regardless of their ability to pay. Most third-party insurance is accepted. Visit http://www.WoodCountyHealth.org for more details.

Continued here:
Community support urged for breastfeeding moms and babies - Press Publications Inc.

Physiology

Pizza Study Shows Body’s Resilience to ‘Pigging Out’ – HealthDay News

FRIDAY, Aug. 7, 2020 (HealthDay News) -- Ever felt guilty for that occasional binge on high-calorie, fatty foods?

Relax: A new study of folks overindulging on pizza finds that if you're healthy and you don't 'pig out' regularly, your body deals with it just fine.

British researchers looked at the effects of eating until not just full, but so full that the participants could not take another bite. Then, they tested the blood of the 14 healthy young men who participated in the study to determine whether there were any changes in blood sugar, blood fats, insulin and other hormones.

The team discovered that even when the men had eaten double the amount of pizza that it would take to make them comfortably full, their blood tests showed no negative consequences.

"I think that's the really remarkable thing here, that we have a huge capacity to overeat and, despite that huge capacity, the body does really quite well at controlling blood sugars and blood fat after that meal," said study author James Betts, a professor of metabolic physiology at the University of Bath's Centre for Nutrition, Exercise and Metabolism.

Betts said it was notable both that the body's response kept blood sugar and lipids under control after such a big meal, and that it was possible for participants to consume so much excess food.

When eating until full, they averaged the equivalent of a large pizza. When eating until maximally full, they ate about two large pizzas, Betts said.

"We expected people to eat more when they were asked to go beyond full, but we expected that to be slightly more," Betts said. "We were really amazed that it was almost exactly 100% more."

The study was published online recently in the British Journal of Nutrition.

Betts and one of his co-authors stumbled upon the idea for the study while traveling to a conference. The only open airport restaurant was a McDonald's, so they each got a McMuffin breakfast sandwich.

"We ate those and enjoyed them and said, 'Oh, I could eat another one,'" Betts said. "That prompted a discussion of 'How many do you think you could eat?' and 'What would be the physiological responses to eating more and more?'"

While researching during the long flight, they discovered there had been no previous studies about eating beyond full, Betts said.

They chose pizza because it tastes good, so people would keep eating. Its high fat and carbohydrate content offered a big challenge to the body, Betts said.

Typically, blood sugar and blood lipids increase in response to how much a person eats, Betts said. A small meal will result in fewer changes than a medium meal, for example.

Yet, after overeating, blood sugar was no higher than after a normal meal. Blood lipids such as triglycerides were slightly higher, even though fat consumption was double. Insulin, which is released to control blood sugar, was 50% higher than normal. Hormones that increase feelings of fullness changed the most.

Connie Diekman, a food nutrition consultant in St. Louis, said the study documents what scientists already understand about the body and its ability to process food. Sometimes people get confused when wondering whether they are eating right, should consume fewer carbs, eat fewer fats or should try something like a Keto diet or intermittent fasting, Diekman said.

"I think it does demonstrate very nicely that our body knows what to do with the food we eat. It knows how to fuel us well," Diekman said.

Of course, Diekman added, constant overeating would challenge how well insulin can do its job and how well the body can move fat without having a lingering impact on blood lipids. This shows that it's OK to have a larger meal for a special occasion, she said.

"You should enjoy the meal," Diekman said, "and then you get back to your regular eating plan."

The study was limited to individuals who were healthy and lean. They ranged in age from 24 to 37. Only men volunteered. A future study may look at the impact of overeating on people who are overweight or have health issues, Betts said.

Though a one-time indulgent meal appears to be fine for a healthy person, Betts said that he hopes the message is clear that this isn't meant for people who are unhealthy or for indulging all the time.

"If you've got a diet that is already really very healthy and an active lifestyle to go with it, then these overindulgences can be even more frequent without imbalancing everything else," Betts said. "How often is too often really comes down to wider choices in the lifestyle."

More information

There's more on eating healthy at the U.S. Centers for Disease Control and Prevention.

SOURCES: James Betts, Ph.D., professor, metabolic physiology, Centre for Nutrition, Exercise and Metabolism, University of Bath, England; Connie Diekman, M.Ed., R.D., L.D., food nutrition consultant, St. Louis; British Journal of Nutrition, April 6, 2020, online

Excerpt from:
Pizza Study Shows Body's Resilience to 'Pigging Out' - HealthDay News

Physiology

Brain scientists haven’t been able to find major differences between women’s and men’s brains, despite over a century of searching – The Conversation…

People have searched for sex differences in human brains since at least the 19th century, when scientist Samuel George Morton poured seeds and lead shot into human skulls to measure their volumes. Gustave Le Bon found mens brains are usually larger than womens, which prompted Alexander Bains and George Romanes to argue this size difference makes men smarter. But John Stuart Mill pointed out, by this criterion, elephants and whales should be smarter than people.

So focus shifted to the relative sizes of brain regions. Phrenologists suggested the part of the cerebrum above the eyes, called the frontal lobe, is most important for intelligence and is proportionally larger in men, while the parietal lobe, just behind the frontal lobe, is proportionally larger in women. Later, neuroanatomists argued instead the parietal lobe is more important for intelligence and mens are actually larger.

In the 20th and 21st centuries, researchers looked for distinctively female or male characteristics in smaller brain subdivisions. As a behavioral neurobiologist and author, I think this search is misguided because human brains are so varied.

The largest and most consistent brain sex difference has been found in the hypothalamus, a small structure that regulates reproductive physiology and behavior. At least one hypothalamic subdivision is larger in male rodents and humans.

But the goal for many researchers was to identify brain causes of supposed sex differences in thinking not just reproductive physiology and so attention turned to the large human cerebrum, which is responsible for intelligence.

Within the cerebrum, no region has received more attention in both race and sex difference research than the corpus callosum, a thick band of nerve fibers that carries signals between the two cerebral hemispheres.

In the 20th and 21st centuries, some researchers found the whole corpus callosum is proportionally larger in women on average while others found only certain parts are bigger. This difference drew popular attention and was suggested to cause cognitive sex differences.

But smaller brains have a proportionally larger corpus callosum regardless of the owners sex, and studies of this structures size differences have been inconsistent. The story is similar for other cerebral measures, which is why trying to explain supposed cognitive sex differences through brain anatomy has not been very fruitful.

Even when a brain region shows a sex difference on average, there is typically considerable overlap between the male and female distributions. If a traits measurement is in the overlapping region, one cannot predict the persons sex with confidence. For example, think about height. I am 57". Does that tell you my sex? And brain regions typically show much smaller average sex differences than height does.

Neuroscientist Daphna Joel and her colleagues examined MRIs of over 1,400 brains, measuring the 10 human brain regions with the largest average sex differences. They assessed whether each measurement in each person was toward the female end of the spectrum, toward the male end or intermediate. They found that only 3% to 6% of people were consistently female or male for all structures. Everyone else was a mosaic.

When brain sex differences do occur, what causes them?

A 1959 study first demonstrated that an injection of testosterone into a pregnant rodent causes her female offspring to display male sexual behaviors as adults. The authors inferred that prenatal testosterone (normally secreted by the fetal testes) permanently organizes the brain. Many later studies showed this to be essentially correct, though oversimplified for nonhumans.

Researchers cannot ethically alter human prenatal hormone levels, so they rely on accidental experiments in which prenatal hormone levels or responses to them were unusual, such as with intersex people. But hormonal and environmental effects are entangled in these studies, and findings of brain sex differences have been inconsistent, leaving scientists without clear conclusions for humans.

While prenatal hormones probably cause most brain sex differences in nonhumans, there are some cases where the cause is directly genetic.

This was dramatically shown by a zebra finch with a strange anomaly it was male on its right side and female on its left. A singing-related brain structure was enlarged (as in typical males) only on the right, though the two sides experienced the same hormonal environment. Thus, its brain asymmetry was not caused by hormones, but by genes directly. Since then, direct effects of genes on brain sex differences have also been found in mice.

Many people assume human brain sex differences are innate, but this assumption is misguided.

Humans learn quickly in childhood and continue learning alas, more slowly as adults. From remembering facts or conversations to improving musical or athletic skills, learning alters connections between nerve cells called synapses. These changes are numerous and frequent but typically microscopic less than one hundredth of the width of a human hair.

Studies of an unusual profession, however, show learning can change adult brains dramatically. London taxi drivers are required to memorize the Knowledge the complex routes, roads and landmarks of their city. Researchers discovered this learning physically altered a drivers hippocampus, a brain region critical for navigation. London taxi drivers posterior hippocampi were found to be larger than nondrivers by millimeters more than 1,000 times the size of synapses.

[Deep knowledge, daily. Sign up for The Conversations newsletter.]

So its not realistic to assume any human brain sex differences are innate. They may also result from learning. People live in a fundamentally gendered culture, in which parenting, education, expectations and opportunities differ based on sex, from birth through adulthood, which inevitably changes the brain.

Ultimately, any sex differences in brain structures are most likely due to a complex and interacting combination of genes, hormones and learning.

See the original post:
Brain scientists haven't been able to find major differences between women's and men's brains, despite over a century of searching - The Conversation...

Genetics

Generational Equity Advises New Generation Genetics in its Sale to Swissgenetics International – Business Wire

DALLAS--(BUSINESS WIRE)--Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, New Generation Genetics to Swissgenetics International. The acquisition closed July 1, 2020 and details were not disclosed.

New Generation Genetics (NGG), located in Fort Atkinson, Wisconsin, has a primary goal of providing its customers with the best Brown Swiss genetics in the industry. NGG focuses solely on Brown Swiss, giving them the advantage over their competitors. The Company has over 50 years of Brown Swiss A.I. experience combined. They currently offer top bulls for Milk, Type, Net Merit, Sire Conception Rate (SCR), Fat, Protein, and PPR Index. They currently sample only the top genomic bulls and continue to lead the breed by sampling 12 young bulls per year.

Swissgenetics International is located in Zollikofen, Switzerland. Successful milk and beef producers rely on sustainable breeding strategies and professional production methods. To achieve this, high-performance and healthy animals are needed. The genetics programs from Swissgenetics are aligned consistently to meet and exceed these requirements. Through the testing programs operated in partnership with breeders and breeding organizations, marketable and future-oriented genetics are developed at an international level. Beneficial breeding cooperation assumes mutual trust between genetics providers and breeders. This requires high levels of competence and transparency on both sides. Swissgenetics is a leader in this field.

Generational Equity Executive Managing Director of M&A Central Region, Michael Goss, and his team lead by Managing Director Mergers & Acquisitions, Stephen Dinehart, with support from Managing Director Mergers & Acquisition, Ryan Johnson, successfully closed the deal. Senior Managing Director Joe Van Voorhis established the initial relationship with NGG.

This is a great acquisition for the Brown Swiss producer family combining two of the major players in Brown Swiss Genetics, said Dinehart. It is a win for both the customers and employees of Swissgenetics and NGG.

About Generational Equity

Generational Equity, Generational Capital Markets (member FINRA/SIPC), Generational Wealth Advisors, Generational Consulting Group, and DealForce are part of the Generational Group, which is headquartered in Dallas and is one of the leading M&A advisory firms in North America.

With over 250 professionals located throughout North America, the companies help business owners release the wealth of their business by providing growth consulting, merger, acquisition, and wealth management services. Their six-step approach features strategic and tactical growth consulting, exit planning education, business valuation, value enhancement strategies, M&A transactional services, and wealth management.

The M&A Advisor named the company the 2016, 2017, and 2018 Investment Banking Firm of the Year. For more information, visit https://www.genequityco.com/ or the Generational Equity press room.

Go here to see the original:
Generational Equity Advises New Generation Genetics in its Sale to Swissgenetics International - Business Wire

Genetics

Could induced pluripotent stem cells be the breakthrough genetics has been waiting for? – The New Economy

Embryonic stem cells. The ethical issues associated with stem cell research could be resolved through the use of induced pluripotent stem cells, which are derived from fully committed and differentiated cells of the adult body

The almost miraculous benefits that stem cells may one day deliver have long been speculated on. Capable of becoming different types of cells, they offer huge promise in terms of transplant and regenerative medicine. It is, however, also a medical field that urges caution one that must constantly battle exaggeration. If stem cells do in fact hold the potential to reverse the ageing process, for example, then such breakthroughs remain many years away.

Recently, though, the field has had cause for excitement. In 2006, Japanese researcher Shinya Yamanaka discovered that mature cells could be reprogrammed to become pluripotent, meaning they can give rise to any cell type of the body. In 2012, the discovery of these induced pluripotent stem cells (iPSCs) saw Yamanaka and British biologist John Gurdon awarded the Nobel Prize in Physiology or Medicine. Since then, there has been much talk regarding the potential iPSCs possess, not only for the world of medicine, but for society more generally, too.

A big stepHistorically, one of the major hurdles preventing further research into stem cells has been an ethical one. Until the discovery of iPSCs, embryonic stem cells (ESCs) represented the predominant area of research, with cells being taken from preimplantation human embryos. This process, however, involves the destruction of the embryo and, therefore, prevents the development of human life. Due to differences in opinion over when life is said to begin during embryonic development, stem cell researchers face an ethical quandary.

The promise of significant health benefits and new revenue streams has led some clinics to offer unproven stem cell treatments to individuals

With iPSCs, though, no such dilemmas exist. IPSCs are almost identical to ESCs but are derived from fully committed and differentiated cells of the adult body, such as a skin cell. Like ESCs, iPSCs are pluripotent and, as they are stem cells, can self-renew and differentiate, remaining indefinitely propagated and retaining the ability to give rise to any human cell type over time.

One important distinction to make is that both ESCs and iPSCs do not exist in nature, Vittorio Sebastiano, Assistant Professor (Research) of Obstetrics and Gynaecology (Reproductive and Stem Cell Biology) at Stanford Universitys Institute for Stem Cell Biology and Regenerative Medicine, told The New Economy. They are both beautiful laboratory artefacts. This means that at any stage of development, you cannot find ESCs or iPSCs in the developing embryo, foetus or even in the postnatal or adult body. Both ESCs and iPSCs can only be established and propagated in the test tube.

The reason neither ESCs nor iPSCs can be found in the body is that they harbour the potential to be very dangerous. As Sebastiano explained, these cells could spontaneously differentiate into tumorigenic masses because of their intrinsic ability to give rise to any cell type of the body. Over many years of research, scientists have learned how to isolate parts of the embryo (in the case of ESCs) and apply certain culture conditions that can lock cells in their proliferative and stem conditions. The same is true for iPSCs.

To create iPSCs, scientists take adult cells and exogenously provide a cocktail of embryonic factors, known as Yamanaka factors, for a period of two to three weeks. If the expression of such factors is sustained for long enough, they can reset the programme of the adult cells and establish an embryonic-like programme.

Turning back the clockThere is already a significant body of research dedicated to how stem cells can be used to treat disease. For example, mesenchymal stem cells (usually taken from adult bone marrow) have been deployed to treat bone fractures or as treatments for autoimmune diseases. It is hoped that iPSCs could hold the key for many more treatments.

Global stem cell market:25.5%Expected compound annual growth rate (2018-24)$467bnExpected market value (2024)

IPSCs are currently utilised to model diseases in vitro for drug screening and to develop therapies that one day will be implemented in people, Sebastiano explained. Given their ability to differentiate into any cell type, iPSCs can be used to differentiate into, for example, neurons or cardiac cells, and study specific diseases. In addition, once differentiated they can be used to test drugs on the relevant cell type. Some groups and companies are developing platforms for cell therapy, and I am personally involved in two projects that will soon reach the clinical stage.

Perhaps the most exciting prospects draw on iPSCs regenerative properties. Over time, cells age for a variety of reasons namely, increased oxidative stress, inflammation and exposure to pollutants or sunlight, among others. All these inputs lead to an accumulation of epigenetic mistakes those that relate to gene expression rather than an alteration of the genetic code itself in the cells, which, over time, results in the aberrant expression of genes, dysfunctionality at different levels, reduced mitochondrial activity, senescence and more besides. Although the epigenetic changes that occur with time may not be the primary cause of ageing, the epigenetic landscape ultimately affects and controls cell functionality.

What we have shown is that, if instead of being expressed for two weeks we express the reprogramming factors for a very short time, then we see that the cells rejuvenate without changing their identity, Sebastiano said. In other words, if you take a skin cell and express the reprogramming genes for two to four days, what you get is a younger skin cell.

By reprogramming a cell into an iPSC, you end up with an embryonic-like cell the reprogramming erases any epigenetic errors. If expressed long enough, it erases the epigenetic information of cell identity, leaving embryonic-like cells that are also young.

Slow and steadyAs with any scientific advancement, financial matters are key. According to Market Research Engine, the global stem cell market is expected to grow at a compound annual growth rate of 25.5 percent between 2018 and 2024, eventually reaching a market value of $467bn. The emergence of iPSCs has played a significant role in shaping these predictions, with major bioscience players, such as Australias Mesoblast and the US Celgene, working on treatments involving this particular type of stem cell.

The business potential around stem cell research is huge, Sebastiano told The New Economy. [Particularly] when it comes to developing cell banks for which we have detailed genetic information and, for example, studying how different drugs are toxic or not on certain genetic backgrounds, or when specific susceptibility mutations are present.

Unfortunately, even as the business cases for iPSC treatments increase, a certain degree of caution must be maintained. The promise of significant health benefits and new revenue streams has led some clinics to offer unproven stem cell treatments to individuals. There have been numerous reports of complications emerging, including the formation of a tumour following experimental stem cell treatment in one particular patient, as recorded in the Canadian Medical Association Journal last year. Such failures risk setting the field back years.

The challenge for researchers now will be one of balance. The potential of iPSCs is huge both in terms of medical progress and business development but can easily be undermined by misuse. Medical advancements, particularly ones as profound as those associated with iPSCs, simply cannot be rushed.

Go here to read the rest:
Could induced pluripotent stem cells be the breakthrough genetics has been waiting for? - The New Economy

Genetics

Genetics company adds COVID-19 testing to services – Business Times of Western Colorado

About Wordfence

Wordfence is a security plugin installed on over 3 million WordPress sites. The owner of this site is using Wordfence to manage access to their site.

You can also read the documentation to learn about Wordfence's blocking tools, or visit wordfence.com to learn more about Wordfence.

Read the rest here:
Genetics company adds COVID-19 testing to services - Business Times of Western Colorado

Genetics

Predictive Genetic Testing and Consumer/Wellness Genomics Market Analytical Overview and Size(Value and Volume) by 2025 – Cole of Duty

Predictive Genetic Testing and Consumer/Wellness Genomics Market: Snapshot

Genetic testing comprises examination of ones DNA. The term DNA refers to the chemical database that is responsible for conveying the instructions for functions that need to be performed by the body. Genetic testing is capable of revealing changes or mutations in the genes of living beings, which might result in any kind of disease or illness in the body.

Get Exclusive PDF Sample Copy Of This Report:https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1274

Predictive genetic testingrefers to the utilization of genetic testing methods in an asymptomatic individual to make a prediction about risk of contacting particular disease in future. These tests are regarded as representation of emerging class of medical tests, which differ in fundamental ways from the usual diagnostic tests.

The global predictive genetic testing and consumer/wellness genomics marketis likely to gather momentum owing to the benefits offered by predictive genetic testing.

The benefits of predictive genetic testing are

The global predictive genetic testing and consumer/wellness genomics marketis influenced by reducing cost of genetic sequencing and technological advancement in the field of genetics. North America is expected to emerge as a prominent region for the global predictive genetic testing and consumer/wellness genomics market in years to come due to high adoption rates of latest technologies in all fields.

Over centauries human DNA has undergone tremendous alteration due to evolutionary and lifestyle changes. They have led to both, advantages and disadvantages over the years. Some have given the mankind a deserving edge over other creatures while the others have led to disorders and diseases. Predictive genetic testing and consumer/wellness genomics market thrives on the growing demand for understanding the lineage of a certain gene pool to identify disorders that could manifest in the later or early stage of a human life. The surging demand for understanding the family history or studying the nature of certain diseases has given the global market for predictive genetic testing and consumer/wellness genomics market adequate fodder for growth in the past few years.

This new class of medical tests are aimed at reducing the risk of morbidity and mortality amongst consumers. The thorough surveillance and screening of a certain gene pool can allow an individual to avoid conditions that disrupt normal existence through preventive measures. The clinical utility of these tests remains unassessed. Therefore, increasing research and development by pharmaceutical companies to develop new drugs by understanding diseases and disorders is expected to favor market growth.

Unlike conventional diagnostic testing, predictive genetic testing identifies the risk associated with potential conditions. In certain cases it is also capable of stating when the disease may appear and the how severe will it be. Thus, this form of testing is expected to allow consumers to take up wellness measurements well in time to lead a life of normalcy, characterized by good health.

Buy This Report @https://www.tmrresearch.com/checkout?rep_id=1274<ype=S

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Overview

Predictive genetic testing are used to identify gene mutations pertaining to the disorders that surface at a considerably later stage in life after birth. These tests are particularly beneficial for people from a family with a history of genetic disorder, although they themselves show no symptoms of the disorder at the time of testing. Genetic testing promises to revolutionize the healthcare sector, providing crucial diagnostic details related to diverse verticals such as heart disease, autism, and cancer. As the healthcare sector touches new peaks, the global predictive genetic testing and consumer/wellness genomics market is projected to expand at a healthy growth rate during the forecast period of 2017 to 2025.

This report on the global market for predictive genetic testing and consumer/wellness genomics analyzes all the important factors that may influence the demand in the near future and forecasts the condition of the market until 2025. It has been created using proven research methodologies such as SWOT analysis and Porters five forces. One of the key aspect of the report is the section on company profiles, wherein several leading players have been estimated for their market share and analyzed for their geographical presence, product portfolio, and recent strategic developments such as mergers, acquisitions, and collaborations.

The global predictive genetic testing and consumer/wellness genomics market, on the basis of test type, can be segmented into predictive testing, consumer genomics, and wellness genetics. The segment of predictive testing can be sub-segmented into genetic susceptibility test, predictive diagnostics, and population screening programs, whereas the segment of wellness genetics can be further divided into nutria genetics, skin and metabolism genetics, and others.

By application, the market can be segmented into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Parkinsons or Alzheimers disease, urologic screening or prostate cancer screening, orthopedic and musculoskeletal screening, and other cancer screening. Geographically, the report studies the opportunities available in regions such as Asia Pacific, Europe, North America, and the Middle East and Africa.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Trends and Opportunities

Increasing number of novel partnership models, rapidly decreasing cost of genetic sequencing, and introduction of fragmented point-solutions across the genomics value chain as well as technological advancements in cloud computing and data integration are some of the key factors driving the market. On the other hand, the absence of well-defined regulatory framework, low adoption rate, and ethical concerns regarding the implementation, are expected to hinder the growth rate during the forecast period. Each of these factors have been analyzed in the report and their respective impacts have been anticipated.

Currently, the segment of predictive genetic cardiovascular screening accounts for the maximum demand, and increased investments in the field is expected to maintain it as most lucrative segment. On the other hand, more than 70 companies are currently engaged in nutrigenomics, which is expected to further expand the market.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Regional Outlook

Owing to robust healthcare infrastructure, prevalence of cardiovascular diseases, and high adoptability rate of new technology makes North America the most lucrative region, with most of the demand coming from the country of the U.S. and Canada. Several U.S. companies hold patents, which further extends the outreach of the market in the region of North America.

Companies mentioned in the research report

23andMe, Inc, BGI, Genesis Genetics, Illumina, Inc, Myriad Genetics, Inc, Pathway Genomics, Color Genomics Inc., and ARUP Laboratories are some of the key companies currently operating in global predictive genetic testing and consumer/wellness genomics market. Various forms of strategic partnerships with operating company and smaller vendors with novel ideas helps these leading players maintain their position in the market.

To know more about the table of contents, you can click @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1274

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in todays supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Here is the original post:
Predictive Genetic Testing and Consumer/Wellness Genomics Market Analytical Overview and Size(Value and Volume) by 2025 - Cole of Duty

Genetics

Seattle Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2020 Financial Results on July 30, 2020 – Yahoo Finance

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its second quarter 2020 financial results on Thursday, July 30, 2020 after the close of financial markets. Following the announcement, Company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows:

Thursday, July 30, 20201:30 p.m. Pacific Time / 4:30 p.m. Eastern Time

About Seattle Genetics

Seattle Genetics, Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in peoples lives. ADCETRIS (brentuximab vedotin) and PADCEVTM (enfortumab vedotin-ejfv) use the Companys industry-leading antibody-drug conjugate (ADC) technology. ADCETRIS is approved in certain CD30-expressing lymphomas, and PADCEV is approved in certain metastatic urothelial cancers. TUKYSATM (tucatinib), a small molecule tyrosine kinase inhibitor, is approved in certain HER2-positive metastatic breast cancers. The Company is headquartered in the Seattle, Washington area, with locations in California, Switzerland and the European Union. For more information on our robust pipeline, visit http://www.seattlegenetics.com and follow @SeattleGenetics on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200709005173/en/

Contacts

Investors Peggy Pinkston(425) 527-4160ppinkston@seagen.com

Media Monique Greer(425) 527-4641mgreer@seagen.com

Read more from the original source:
Seattle Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2020 Financial Results on July 30, 2020 - Yahoo Finance

Neuroscience

Kernel raises $53M to expand access to its Neuroscience as a Service platform – VatorNews

The company was founded by Braintree's Bryan Johnson

Kernelis a company pioneering a new space:Neuroscience as a Service (NaaS), in which it noninvasively records brain activity, allowing its customers to measure and quantify cognition on-demand.

It's a fairly new technology, and it's caught the interest of investors, who just poured $53 million into the company, it was announced on Thursday. The round was led by General Catalyst, with participation from Khosla Ventures, Eldridge, Manta Ray Ventures, Tiny Blue Dot and Bryan Johnson, founder and CEO of Kernel.

While this is being called a Series C round, it's actually the first outside funding the company has taken; until now, it had raised $54 million, all from Johnson's own pocket, bringing its total funding to $107 million. Johnson was previously the founder, chairman and CEO of payment company Braintree, which was acquired by eBay for $800 million in 2013.

Founded in 2016, Kernel's platform is powered by two brain recording technologies: one is called "Flux," which is short for "magnetic flux." It detects the magnetic fields generated by collective neural activity in the brain. The other is called "Flow," short for "blood flow," and it detects cortical hemodynamics, which is representative of neural activity.

Kernel's customers can use the technology to do things such as explore biomarkers, but the company is also getting a lot of interest from customers trying to use it for improving machine learning algorithms for such applications as image recognition and voice recognition.

One group that Kernel is working with, for example, is trying to quantify a neural assessment, instead of relying on qualitative questions and self-reporting.Another company is using the neural data to improve image recognition algorithms; Kernal is able to provide vast amounts of brain data that can be fed to a deep neural network for a much higher representation of an image.

Along with the funding, it was revealed that Quentin Clark, Managing Director at General Catalyst, has joined the Board of Directors at Kernel.

"The vision fueling Kernel is one of the most audacious imaginable." Clark said in a statement. "But that ambition has a passionate and committed founder and team, and pragmatic engineering work to back it up. Kernel's engineering accomplishments have the potential to enable more neuroscience progress in the next few years than has been accomplished in the last few decades."

Read more:
Kernel raises $53M to expand access to its Neuroscience as a Service platform - VatorNews

Neuroscience

Neuroscience Antibodies & Assays Market Growth By Manufacturers, Countries, Types And Application, End Users And Forecast To 2026 – 3rd Watch News

New Jersey, United States,- Verified Market Research sheds light on the market scope, potential, and performance perspective of the Neuroscience Antibodies & Assays Market by carrying out an extensive market analysis. Pivotal market aspects like market trends, the shift in customer preferences, fluctuating consumption, cost volatility, the product range available in the market, growth rate, drivers and constraints, financial standing, and challenges existing in the market are comprehensively evaluated to deduce their impact on the growth of the market in the coming years. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the Neuroscience Antibodies & Assays market.

The research study includes the latest updates about the COVID-19 impact on the Neuroscience Antibodies & Assays sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Leading Neuroscience Antibodies & Assays manufacturers/companies operating at both regional and global levels:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

Industrial Analysis:

The Neuroscience Antibodies & Assays market report is extensively categorized into different product types and applications. The study has a separate section for explaining the cost of raw material and the revenue returns that are gained by the players of the market.

The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for the Neuroscience Antibodies & Assays sector and can help companies in deciphering the optimum business move to reach their desired business goals.

In Market Segmentation by Types of Neuroscience Antibodies & Assays, the report covers-

Bytype1

In Market Segmentation by Applications of the Neuroscience Antibodies & Assays, the report covers the following uses-

Byapplication1

To get Incredible Discounts on this Premium Report, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=28342&utm_source=3WN&utm_medium=003

The Neuroscience Antibodies & Assays market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Neuroscience Antibodies & Assays market.

This study analyzes the growth of Neuroscience Antibodies & Assays based on the present, past and futuristic data and will render complete information about the Neuroscience Antibodies & Assays industry to the market-leading industry players that will guide the direction of the Neuroscience Antibodies & Assays market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Sales Forecast:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Neuroscience Antibodies & Assays market. Additionally, it includes a share of each segment of the Neuroscience Antibodies & Assays market, giving methodical information about types and applications of the market.

Reasons for Buying Neuroscience Antibodies & Assays Market Report

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It renders an in-depth analysis for changing competitive dynamics.

It presents a detailed analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by performing a pin-point analysis of market segments and by having complete insights of the Neuroscience Antibodies & Assays market.

This report helps the readers understand key product segments and their future.

Have Any Query? Ask Our Expert @ https://www.verifiedmarketresearch.com/product/Neuroscience-Antibodies-&-Assays-Market/?utm_source=3WN&utm_medium=003

In the end, the Neuroscience Antibodies & Assays market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions.

To summarize, the Neuroscience Antibodies & Assays market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

Follow this link:
Neuroscience Antibodies & Assays Market Growth By Manufacturers, Countries, Types And Application, End Users And Forecast To 2026 - 3rd Watch News